Genome editing to 're-write' wrongs

Genome editing to 're-write' wrongs

The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing therapeutics. The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Drug discovery 2018-10, Vol.17 (10), p.689-690
Hauptverfasser: Perry, Mary Ellen, Valdes, Kayla M., Wilder, Elizabeth, Austin, Christopher P., Brooks, Philip J.
Format: Artikel
Sprache:eng
Schlagworte:
631/154/51/201
631/208/1516
Animals
Biomedical and Life Sciences
Biomedicine
Biotechnology
Cancer Research
Clinical trials
comment
CRISPR
Disease
Drug approval
Gene Editing - methods
Gene mutation
Gene therapy
Genes
Genetic engineering
Genetic Therapy - methods
Genome editing
Genome, Human - genetics
Genomes
Genomics
Genotypes
Health aspects
Humans
Initiatives
Innovations
Medicinal Chemistry
Molecular Medicine
Mutation
Mutation - genetics
Patients
Pharmacology/Toxicology
Precision medicine
Reproducibility
Working groups
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing therapeutics. The NIH has launched the Somatic Cell Genome Editing (SCGE) programme to accelerate the development of safer and more effective genome-editing therapeutics.
ISSN:1474-1776
1474-1784
DOI:10.1038/nrd.2018.91